Managing cancer risk in patients with systemic lupus erythematous

References

• Abu-Shakra M, Gladman DD, Urowitz MB. Malignancy in systemic lupus erythematosus. Arthritis Rheum. 1996 Jun;39(6):1050–1054. PubMed PMID: 8651970.
   PubMedGoogle Scholar
• Pettersson T, Pukkala E, Teppo L, et al. Increased risk of cancer in patients with systemic lupus erythematosus. Ann Rheum Dis. 1992 Apr;51(4):437–439. PubMed PMID: 1586239; PubMed Central PMCID: PMCPMC1004687.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Labrecque J, et al. Cancer risk in systemic lupus: an updated international multi-centre cohort study. J Autoimmun. 2013 May;42:130–135. PubMed PMID: 23410586; PubMed Central PMCID: PMCPMC3646904.
   PubMed Web of Science ®Google Scholar
• Chen YJ, Chang YT, Wang CB, et al. Malignancy in systemic lupus erythematosus: a nationwide cohort study in Taiwan. Am J Med. 2010 Dec;123(12):1150 e1–6. PubMed PMID: 21183006.
   Web of Science ®Google Scholar
• Dreyer L, Faurschou M, Mogensen M, et al. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort. Arthritis Rheum. 2011 Oct;63(10):3032–3037. PubMed PMID: 21953088.
   PubMedGoogle Scholar
• Bjornadal L, Lofstrom B, Yin L, et al. Increased cancer incidence in a Swedish cohort of patients with systemic lupus erythematosus. Scand J Rheumatol. 2002;31(2):66–71. PubMed PMID: 12109649.
   PubMed Web of Science ®Google Scholar
• Mellemkjaer L, Andersen V, Linet MS, et al. Non-Hodgkin’s lymphoma and other cancers among a cohort of patients with systemic lupus erythematosus. Arthritis Rheum. 1997 Apr;40(4):761–768. PubMed PMID: 9125261.
   PubMedGoogle Scholar
• Cibere J, Sibley J, Haga M. Systemic lupus erythematosus and the risk of malignancy. PubMed PMID: 11434573 Lupus. 2001;106:394–400.
   PubMed Web of Science ®Google Scholar
• Ramsey-Goldman R, Mattai SA, Schilling E, et al. Increased risk of malignancy in patients with systemic lupus erythematosus. J Investig Med. 1998 Jun;46(5):217–222. PubMed PMID: 9676054.
   PubMed Web of Science ®Google Scholar
• Chang SL, Hsu HT, Weng SF, et al. Impact of head and neck malignancies on risk factors and survival in systemic lupus erythematosus. Acta Otolaryngol. 2013 Oct;133(10):1088–1095. PubMed PMID: 24032572.
   PubMed Web of Science ®Google Scholar
• Parikh-Patel A, White RH, Allen M, et al. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California. Cancer Causes Control. 2008 Oct;19(8):887–894. PubMed PMID: 18386139; PubMed Central PMCID: PMCPMC4357418.
   PubMed Web of Science ®Google Scholar
• Ni J, Qiu LJ, Hu LF, et al. Lung, liver, prostate, bladder malignancies risk in systemic lupus erythematosus: evidence from a meta-analysis. Lupus. 2014 Mar;23(3):284–292. PubMed PMID: 24429300.
   PubMed Web of Science ®Google Scholar
• Cao L, Tong H, Xu G, et al. Systemic lupus erythematous and malignancy risk: a meta-analysis. PLoS One. 2015;10(4):e0122964. PubMed PMID: 25885411; PubMed Central PMCID: PMCPMC4401738.
   PubMed Web of Science ®Google Scholar
• Kang KY, Kim HO, Yoon HS, et al. Incidence of cancer among female patients with systemic lupus erythematosus in Korea. Clin Rheumatol. 2010 Apr;29(4):381–388. PubMed PMID: 20041274.
   PubMed Web of Science ®Google Scholar
• Nived O, Bengtsson A, Jonsen A, et al. Malignancies during follow-up in an epidemiologically defined systemic lupus erythematosus inception cohort in southern Sweden. Lupus. 2001;10(7):500–504. PubMed PMID: 11480849.
   PubMed Web of Science ®Google Scholar
• Ragnarsson O, Grondal G, Steinsson K. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus. PubMed PMID: 14514131 Lupus. 2003;129:687–691.
   PubMed Web of Science ®Google Scholar
• Lin YC, Yen JH, Chang SJ, et al. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study. Lupus. 2012 Oct;21(11):1250–1256. PubMed PMID: 22740427.
   PubMed Web of Science ®Google Scholar
• Najafi M, Sadjadei N, Eftekhari K, et al. Prevalence of celiac disease in children with autoimmune hepatitis and vice versa. Iran J Pediatr. 2014 Dec;24(6):723–728. PubMed PMID: 26019778; PubMed Central PMCID: PMCPMC4442834.
   PubMed Web of Science ®Google Scholar
• Tallbacka KR, Pettersson T, Pukkala E. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up. Scand J Rheumatol. 2018 Jan 10:1–4 PubMed PMID: 29318934. Doi:10.1080/03009742.2017.1384054.
   PubMedGoogle Scholar
• Azrielant S, Tiosano S, Watad A, et al. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study. Immunol Res. 2017 Apr;65(2):464–469. 10.1007/s12026-016-8885-8. PubMed PMID: 28091805.
   PubMed Web of Science ®Google Scholar
• Apor E, O’Brien J, Stephen M, et al. Systemic lupus erythematosus is associated with increased incidence of hematologic malignancies: a meta-analysis of prospective cohort studies. Leuk Res. 2014 Sep;38(9):1067–1071. PubMed PMID: 25052307.
   PubMed Web of Science ®Google Scholar
• Knight JS, Blayney DW, Somers EC. Patients with systemic lupus erythematosus and haematological malignancy at a tertiary care centre: timing, histopathology and therapy. PubMed PMID: 25452880; PubMed Central PMCID: PMCPMC4246917 Lupus Sci Med. 2014;11:e000051.
   PubMedGoogle Scholar
• Lu M, Bernatsky S, Ramsey-Goldman R, et al. Non-lymphoma hematological malignancies in systemic lupus erythematosus. Oncology. 2013;85(4):235–240. PubMed PMID: 24107608; PubMed Central PMCID: PMCPMC3880772.
   PubMed Web of Science ®Google Scholar
• Chalayer E, Costedoat-Chalumeau N, Beyne-Rauzy O, et al. Bone marrow involvement in systemic lupus erythematosus. QJM. 2017 Nov 1;110(11):701–711. PubMed PMID: 28525589.
   PubMed Web of Science ®Google Scholar
• Anderson LA, Pfeiffer RM, Landgren O, et al. Risks of myeloid malignancies in patients with autoimmune conditions. Br J Cancer. 2009 Mar 10;100(5):822–828. PubMed PMID: 19259097; PubMed Central PMCID: PMCPMC2653768.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Joseph L, Boivin JF, et al. The relationship between cancer and medication exposures in systemic lupus erythaematosus: a case-cohort study. Ann Rheum Dis. 2008 Jan;67(1):74–79. PubMed PMID: 17545189.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Joseph L, et al. Lymphoma risk in systemic lupus: effects of disease activity versus treatment. Ann Rheum Dis. 2014 Jan;73(1):138–142. PubMed PMID: 23303389; PubMed Central PMCID: PMCPMC3855611.
   PubMed Web of Science ®Google Scholar
• Lofstrom B, Backlin C, Sundstrom C, et al. A closer look at non-Hodgkin’s lymphoma cases in a national Swedish systemic lupus erythematosus cohort: a nested case-control study. Ann Rheum Dis. 2007 Dec;66(12):1627–1632. PubMed PMID: 17517757; PubMed Central PMCID: PMCPMC2095297.
   PubMed Web of Science ®Google Scholar
• Tincani A, Taraborelli M, Cattaneo R. Antiphospholipid antibodies and malignancies. Autoimmun Rev. 2010 Feb;9(4):200–202.. PubMed PMID: 19386286.
   PubMed Web of Science ®Google Scholar
• Tarella C, Gueli A, Ruella M, et al. Lymphocyte transformation and autoimmune disorders. Autoimmun Rev. 2013 Jun;12(8):802–813. PubMed PMID: 23219771.
   PubMed Web of Science ®Google Scholar
• Lofstrom B, Backlin C, Pettersson T, et al. Expression of APRIL in diffuse large B cell lymphomas from patients with systemic lupus erythematosus and rheumatoid arthritis. J Rheumatol. 2011 Sep;38(9):1891–1897. PubMed PMID: 21724695.
   PubMed Web of Science ®Google Scholar
• Cheema GS, Roschke V, Hilbert DM, et al. Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases. Arthritis Rheum. 2001 Jun;44(6):1313–1319. PubMed PMID: 11407690.
   PubMed Web of Science ®Google Scholar
• Zhang J, Roschke V, Baker KP, et al. Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus. J Immunol. 2001 Jan 1;166(1):6–10. PubMed PMID: 11123269.
   PubMed Web of Science ®Google Scholar
• Koyama T, Tsukamoto H, Miyagi Y, et al. Raised serum APRIL levels in patients with systemic lupus erythematosus. Ann Rheum Dis. 2005 Jul;64(7):1065–1067. PubMed PMID: 15576416; PubMed Central PMCID: PMCPMC1755547.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Velasquez Garcia HA, Spinelli JJ, et al. Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma. Lupus Sci Med. 2017;4(1):e000187. PubMed PMID: 29214033; PubMed Central PMCID: PMCPMC5715504.
   PubMedGoogle Scholar
• Nocturne G, Boudaoud S, Miceli-Richard C, et al. Germline and somatic genetic variations of TNFAIP3 in lymphoma complicating primary Sjogren’s syndrome. Blood. 2013 Dec 12;122(25):4068–4076. PubMed PMID: 24159176; PubMed Central PMCID: PMCPMC3862283.
   PubMed Web of Science ®Google Scholar
• Okada Y, Wu D, Trynka G, et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature. 2014 Feb 20;506(7488):376–381. PubMed PMID: 24390342; PubMed Central PMCID: PMCPMC3944098.
   PubMed Web of Science ®Google Scholar
• Ekstrom Smedby K, Vajdic CM, Falster M, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the interlymph consortium. Blood. 2008 Apr 15;111(8):4029–4038. PubMed PMID: 18263783; PubMed Central PMCID: PMCPMC2288717.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Rajan R, et al. Non-Hodgkin’s lymphoma in systemic lupus erythematosus. Ann Rheum Dis. 2005 Oct;64(10):1507–1509. PubMed PMID: 16162903; PubMed Central PMCID: PMCPMC1755239.
   PubMed Web of Science ®Google Scholar
• Hemminki K, Liu X, Ji J, et al. Effect of autoimmune diseases on risk and survival in histology-specific lung cancer. Eur Respir J. 2012 Dec;40(6):1489–1495. PubMed PMID: 22323571.
   PubMed Web of Science ®Google Scholar
• Castro FA, Liu X, Forsti A, et al. Increased risk of hepatobiliary cancers after hospitalization for autoimmune disease. Clin Gastroenterol Hepatol. 2014 Jun;12(6):1038–45 e7. PubMed PMID: 24246767.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Mosca M, Fallahi P, et al. Thyroid cancer in systemic lupus erythematosus: a case-control study. J Clin Endocrinol Metab. 2010 Jan;95(1):314–318. PubMed PMID: 19906791.
   PubMed Web of Science ®Google Scholar
• Liu X, Ji J, Forsti A, et al. Autoimmune disease and subsequent urological cancer. J Urol. 2013 Jun;189(6):2262–2268. PubMed PMID: 23228387.
   PubMed Web of Science ®Google Scholar
• Dey D, Kenu E, Isenberg DA. Cancer complicating systemic lupus erythematosus–a dichotomy emerging from a nested case-control study. Lupus. 2013 Aug;22(9):919–927.. PubMed PMID: 23857987; PubMed Central PMCID: PMCPMC4107831.
   PubMed Web of Science ®Google Scholar
• Nyberg G, Eriksson O, Westberg NG. Increased incidence of cervical atypia in women with systemic lupus erythematosus treated with chemotherapy. Arthritis Rheum. 1981 May;24(5):648–650. PubMed PMID: 7236321.
   PubMedGoogle Scholar
• Blumenfeld Z, Lorber M, Yoffe N, et al. Systemic lupus erythematosus: predisposition for uterine cervical dysplasia. Lupus. 1994 Feb;3(1):59–61. PubMed PMID: 8025589.
   PubMed Web of Science ®Google Scholar
• Ognenovski VM, Marder W, Somers EC, et al. Increased incidence of cervical intraepithelial neoplasia in women with systemic lupus erythematosus treated with intravenous cyclophosphamide. J Rheumatol. 2004 Sep;31(9):1763–1767. PubMed PMID: 15338497.
   PubMed Web of Science ®Google Scholar
• Wadstrom H, Arkema EV, Sjowall C, et al. Cervical neoplasia in systemic lupus erythematosus: a nationwide study. Rheumatology (Oxford). 2017 Apr 1;56(4):613–619. PubMed PMID: 28039412; PubMed Central PMCID: PMCPMC5850736.
   PubMed Web of Science ®Google Scholar
• Kim SC, Glynn RJ, Giovannucci E, et al. Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study. Ann Rheum Dis. 2015 Jul;74(7):1360–1367. PubMed PMID: 24618265; PubMed Central PMCID: PMCPMC4161656.
   PubMed Web of Science ®Google Scholar
• Dugue PA, Lynge E, Rebolj M. Increased risk of high-grade squamous intraepithelial lesions in systemic lupus erythematosus: additional data from Denmark. Autoimmun Rev. 2014 Dec;13(12):1241–1242.. PubMed PMID: 25151614.
   PubMed Web of Science ®Google Scholar
• Dugue PA, Rebolj M, Hallas J, et al. Risk of cervical cancer in women with autoimmune diseases, in relation with their use of immunosuppressants and screening: population-based cohort study. Int J Cancer. 2015 Mar 15;136(6):E711–9. PubMed PMID: 25220731.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Petri M, et al. Smoking is the most significant modifiable lung cancer risk factor in systemic lupus erythematosus. J Rheumatol. 2018 Mar;45(3):393–396. PubMed PMID: 29335347; PubMed Central PMCID: PMCPMC5834350.
   PubMed Web of Science ®Google Scholar
• Wu Y, Hou Q. Systemic lupus erythematous increased lung cancer risk: evidence from a meta-analysis. J Cancer Res Ther. 2016 Apr-Jun;12(2):721–724.. PubMed PMID: 27461640.
   PubMed Web of Science ®Google Scholar
• Bin J, Bernatsky S, Gordon C, et al. Lung cancer in systemic lupus erythematosus. Lung Cancer. 2007 Jun;56(3):303–306. PubMed PMID: 17291624.
   PubMed Web of Science ®Google Scholar
• Rosenberger A, Sohns M, Friedrichs S, et al. Gene-set meta-analysis of lung cancer identifies pathway related to systemic lupus erythematosus. PLoS One. 2017;12(3):e0173339. PubMed PMID: 28273134; PubMed Central PMCID: PMCPMC5342225.
   PubMed Web of Science ®Google Scholar
• Turner-Warwick M, Lebowitz M, Burrows B, et al. Cryptogenic fibrosing alveolitis and lung cancer. Thorax. 1980 Jul;35(7):496–499. PubMed PMID: 7434310; PubMed Central PMCID: PMCPMC471320.
   PubMed Web of Science ®Google Scholar
• Hubbard R, Venn A, Lewis S, et al. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med. 2000 Jan;161(1):5–8. PubMed PMID: 10619790.
   PubMed Web of Science ®Google Scholar
• Lewin G, Morissette K, Dickinson J, et al. Recommendations on screening for lung cancer. CMAJ. 2016 Apr 5;188(6):425–432. PubMed PMID: 26952527; PubMed Central PMCID: PMCPMC4818132. eng.
   PubMed Web of Science ®Google Scholar
• Mazzone PJ, Silvestri GA, Patel S, et al. Screening for lung cancer: CHEST guideline and expert panel report. Chest. 2018 Apr;153(4):954–985. PubMed PMID: 29374513; eng.
   PubMed Web of Science ®Google Scholar
• Haugen BR. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: what is new and what has changed? Cancer. 2017 Feb 1;123(3):372–381.. PubMed PMID: 27741354.
   PubMed Web of Science ®Google Scholar
• Vaccarella S, Franceschi S, Bray F, et al. Worldwide thyroid-cancer epidemic? the increasing impact of overdiagnosis. N Engl J Med. 2016 Aug 18;375(7):614–617. PubMed PMID: 27532827.
   PubMed Web of Science ®Google Scholar
• Topstad D, Dickinson JA. Thyroid cancer incidence in Canada: a national cancer registry analysis. CMAJ Open. 2017 Aug 11;5(3):E612–E616.. PubMed PMID: 28807924; PubMed Central PMCID: PMCPMC5621959.
   PubMedGoogle Scholar
• Society CC. Signs and symptoms. [cited 2018 May 31st]. Available from http://www.cancer.ca/en/cancer-information/cancer-type/thyroid/signs-and-symptoms/?region=qcTyroid cancer
   Google Scholar
• Ahmed MM, Berney SM, Wolf RE, et al. Prevalence of active hepatitis C virus infection in patients with systemic lupus erythematosus. Am J Med Sci. 2006 May;331(5):252–256. PubMed PMID: 16702794.
   PubMed Web of Science ®Google Scholar
• Ringelhan M, McKeating JA, Protzer U. Viral hepatitis and liver cancer. Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). PubMed PMID: 28893941; PubMed Central PMCID: PMCPMC5597741. Doi:10.1098/rstb.2016.0274.
   PubMed Web of Science ®Google Scholar
• Keeling S, Avina-Zubieta JA, Barr S, et al. GRADE-based recommendations for the diagnosis and monitoring of systemic lupus erythematosus in Canada [abstract]. In: Proceedings of the Annual Meeting of the American College of Rheumatology; 2017 Nov 3–8;. San Diego CA: ACR/ARHP; 2017. Abstract number 1599. Available from https://acrabstracts.org/abstract/grade-based-recommendations-for-the-diagnosis-and-monitoring-of-systemic-lupus-erythematosus-in-canada/.
   Google Scholar
• Mosca M, Tani C, Aringer M, et al. European league against rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis. 2010 Jul;69(7):1269–1274. PubMed PMID: 19892750; PubMed Central PMCID: PMCPMC2952401. eng.
   PubMed Web of Science ®Google Scholar
• van Assen S, Agmon-Levin N, Elkayam O, et al. EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2011 Mar;70(3):414–422. PubMed PMID: 21131643.
   PubMed Web of Science ®Google Scholar
• Mao S, Shen H, Zhang J. Systemic lupus erythematosus and malignancies risk. J Cancer Res Clin Oncol. 2016 Jan;142(1):253–262. 10.1007/s00432-015-2032-0. PubMed PMID: 26319223.
   PubMed Web of Science ®Google Scholar
• International Agency of Research on Cancer. IARC monographs on the evaluation of carcinogenic risks to humans. Vol.26: some antineoplastic and immunosuppressive agents. Lyon (France): International Agency for Research on Cancer; 1981.
   Google Scholar
• Monach PA, Arnold LM, Merkel PA. Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review. Arthritis Rheum. 2010 Jan;62(1):9–21.. PubMed PMID: 20039416.
   PubMed Web of Science ®Google Scholar
• Tessier-Cloutier B, Clarke AE, Pineau CA, et al. What investigations are needed to optimally monitor for malignancies in SLE? Lupus. 2015 Jul;24(8):781–787. PubMed PMID: 25742688.
   PubMed Web of Science ®Google Scholar
• Bongu A, Chang E, Ramsey-Goldman R. Can morbidity and mortality of SLE be improved? Best Pract Res Clin Rheumatol. 2002 Apr;16(2):313–332.. PubMed PMID: 12041956.
   PubMed Web of Science ®Google Scholar
• Wang HL, Zhou YM, Zhu GZ, et al. Malignancy as a comorbidity in rheumatic diseases: a retrospective hospital-based study. Clin Rheumatol. 2018 Jan;37(1):81–85. 10.1007/s10067-017-3676-8. PubMed PMID: 28508950; eng.
   PubMed Web of Science ®Google Scholar
• Zard E, Arnaud L, Mathian A, et al. Increased risk of high grade cervical squamous intraepithelial lesions in systemic lupus erythematosus: A meta-analysis of the literature. Autoimmun Rev. 2014 Jul;13(7):730–735. PubMed PMID: 24657969.
   PubMed Web of Science ®Google Scholar
• Santana IU, Gomes AN, Lyrio LD, et al. Systemic lupus erythematosus, human papillomavirus infection, cervical pre-malignant and malignant lesions: a systematic review. Clin Rheumatol. 2011 May;30(5):665–672. PubMed PMID: 21072553.
   PubMed Web of Science ®Google Scholar
• Nath R, Mant C, Luxton J, et al. High risk of human papillomavirus type 16 infections and of development of cervical squamous intraepithelial lesions in systemic lupus erythematosus patients. Arthritis Rheum. 2007 May 15;57(4):619–625. PubMed PMID: 17471531.
   PubMedGoogle Scholar
• Klumb EM, Pinto AC, Jesus GR, et al. Are women with lupus at higher risk of HPV infection? Lupus. 2010 Nov;19(13):1485–1491. PubMed PMID: 20605875.
   PubMed Web of Science ®Google Scholar
• Tam LS, Chan PK, Ho SC, et al. Natural history of cervical papilloma virus infection in systemic lupus erythematosus - a prospective cohort study. J Rheumatol. 2010 Feb;37(2):330–340. PubMed PMID: 20032093.
   PubMed Web of Science ®Google Scholar
• Tam LS, Chan AY, Chan PK, et al. Increased prevalence of squamous intraepithelial lesions in systemic lupus erythematosus: association with human papillomavirus infection. Arthritis Rheum. 2004 Nov;50(11):3619–3625. PubMed PMID: 15529372.
   PubMed Web of Science ®Google Scholar
• Wallin KL, Wiklund F, Angstrom T, et al. Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med. 1999 Nov 25;341(22):1633–1638. PubMed PMID: 10572150.
   PubMed Web of Science ®Google Scholar
• Bosch FX, Lorincz A, Munoz N, et al. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol. 2002 Apr;55(4):244–265. PubMed PMID: 11919208; PubMed Central PMCID: PMCPMC1769629. eng.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Gordon C, et al. Factors associated with abnormal Pap results in systemic lupus erythematosus. Rheumatology (Oxford). 2004 Nov;43(11):1386–1389. PubMed PMID: 15280571.
   PubMed Web of Science ®Google Scholar
• Dickinson J, Tsakonas E, Conner Gorber S, et al. Recommendations on screening for cervical cancer. CMAJ. 2013 Jan 8;185(1):35–45. PubMed PMID: 23297138; PubMed Central PMCID: PMCPMC3537778. eng.
   PubMed Web of Science ®Google Scholar
• Society of Obstetricians and Gynaecologists of Canada, Society of Gynecological Oncology of Canada, Society of Canadian Colposcopists. Position statement: recommendations on screening for cervical cancer; 2013.
   Google Scholar
• Report CCD. An Advisory Committee Statement (ACS): STATEMENT ON HUMAN PAPILLOMAVIRUS VACCINE 2007.
   Google Scholar
• Grein IH, Groot N, Lacerda MI, et al. HPV infection and vaccination in systemic lupus erythematosus patients: what we really should know. Pediatr Rheumatol Online J. 2016 Mar 8;14(1):12. 10.1186/s12969-016-0072-x. PubMed PMID: 26956735; PubMed Central PMCID: PMCPMC4782298.
   PubMed Web of Science ®Google Scholar
• Mok CC, Ho LY, Fong LS, et al. Immunogenicity and safety of a quadrivalent human papillomavirus vaccine in patients with systemic lupus erythematosus: a case-control study. Ann Rheum Dis. 2013 May;72(5):659–664. PubMed PMID: 22589375; eng.
   PubMed Web of Science ®Google Scholar
• Markowitz LE, Dunne EF, Saraiya M, et al. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014 Aug 29;63(Rr–05):1–30. PubMed PMID: 25167164; eng.
   PubMed Web of Science ®Google Scholar
• Grushchak S, Mathieu RJ, Orrell KA, et al. Malignant melanoma association with systemic lupus erythematosus in a large midwestern U.S. patient population: a retrospective study. Int J Dermatol. 2018 Apr 20 PubMed PMID: 29676462. Doi:10.1111/ijd.13979.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Joseph L, Belisle P, et al. Bayesian modelling of imperfect ascertainment methods in cancer studies. Stat Med. 2005 Aug 15;24(15):2365–2379. PubMed PMID: 15977290.
   PubMed Web of Science ®Google Scholar
• Moran GW, Lim AW, Bailey JL, et al. Review article: dermatological complications of immunosuppressive and anti-TNF therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2013 Nov;38(9):1002–1024. PubMed PMID: 24099467; eng.
   PubMed Web of Science ®Google Scholar
• Marzano AV, Borghi A, Meroni PL, et al. Immune-mediated inflammatory reactions and tumors as skin side effects of inflammatory bowel disease therapy. Autoimmunity. 2014 May;47(3):146–153. PubMed PMID: 24437626; eng.
   PubMed Web of Science ®Google Scholar
• Hagen JW, Pugliano-Mauro MA. Nonmelanoma skin cancer risk in patients with inflammatory bowel disease undergoing thiopurine therapy: a systematic review of the literature. Dermatol Surg. 2018 Apr;44(4):469–480. PubMed PMID: 29315147; eng.
   PubMed Web of Science ®Google Scholar
• Rizvi SMH, Aagnes B, Holdaas H, et al. Long-term change in the risk of skin cancer after organ transplantation: a population-based nationwide cohort study. JAMA Dermatol. 2017 Dec 1;153(12):1270–1277. PubMed PMID: 29049612; PubMed Central PMCID: PMCPMC5817449. eng.
   PubMed Web of Science ®Google Scholar
• Canadian Cancer Society. Society releases updated sun safety recommendations. 2016.
   Google Scholar
• Johnson MM, Leachman SA, Aspinwall LG, et al. Skin cancer screening: recommendations for data-driven screening guidelines and a review of the US preventive services task force controversy. Melanoma Manag. 2017 Mar;4(1):13–37. PubMed PMID: 28758010; PubMed Central PMCID: PMCPMC5480135.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Foulkes WD, et al. Breast, ovarian, and endometrial malignancies in systemic lupus erythematosus: a meta-analysis. Br J Cancer. 2011 Apr 26;104(9):1478–1481. PubMed PMID: 21487409; PubMed Central PMCID: PMCPMC3101932.
   PubMed Web of Science ®Google Scholar
• Chan K, Clarke AE, Ramsey-Goldman R, et al. Breast cancer in systemic lupus erythematosus (SLE): receptor status and treatment. Lupus. 2018 Jan;27(1):120–123. PubMed PMID: 28595511.
   PubMed Web of Science ®Google Scholar
• Gadalla SM, Amr S, Langenberg P, et al. Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case-control study. Br J Cancer. 2009 Mar 10;100(5):817–821. PubMed PMID: 19190628; PubMed Central PMCID: PMCPMC2651404. eng.
   PubMed Web of Science ®Google Scholar
• Mayorga J, Alpizar-Rodriguez D, Prieto-Padilla J, et al. Prevalence of premature ovarian failure in patients with systemic lupus erythematosus. Lupus. 2016 Jun;25(7):675–683. PubMed PMID: 26678443.
   PubMed Web of Science ®Google Scholar
• Cooper GS, Dooley MA, Treadwell EL, et al. Hormonal and reproductive risk factors for development of systemic lupus erythematosus: results of a population-based, case-control study. Arthritis Rheum. 2002 Jul;46(7):1830–1839. PubMed PMID: 12124867.
   PubMedGoogle Scholar
• Choi MY, Flood K, Bernatsky S, et al. A review on SLE and malignancy. Best Pract Res Clin Rheumatol. 2017 Jun;31(3):373–396. PubMed PMID: 29224679.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Ramsey-Goldman R, Petri M, et al. Breast cancer in systemic lupus. Lupus. 2017 Mar;26(3):311–315. PubMed PMID: 27687028; PubMed Central PMCID: PMCPMC5250552.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Easton DF, Dunning A, et al. Decreased breast cancer risk in systemic lupus erythematosus: the search for a genetic basis continues. Lupus. 2012 Jul;21(8):896–899. PubMed PMID: 22495874.
   PubMed Web of Science ®Google Scholar
• Bernatsky SR, Cooper GS, Mill C, et al. Cancer screening in patients with systemic lupus erythematosus. J Rheumatol. 2006 Jan;33(1):45–49. PubMed PMID: 16331804.
   PubMed Web of Science ®Google Scholar